149 related articles for article (PubMed ID: 26451909)
21. The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.
Choi CJ; Tao W; Doddapaneni R; Acosta-Torres Z; Blessing NW; Lee BW; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5912-5923. PubMed ID: 30551199
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.
Yoon JS; Chae MK; Lee SY; Lee EJ
Br J Ophthalmol; 2012 Aug; 96(8):1117-21. PubMed ID: 22661653
[TBL] [Abstract][Full Text] [Related]
23. Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels.
Kim H; Choi YH; Park SJ; Lee SY; Kim SJ; Jou I; Kook KH
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3061-6. PubMed ID: 20053983
[TBL] [Abstract][Full Text] [Related]
24. Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid.
Kook KH; Choi YH; Kim YR; Park SJ; Jou I; Kim SJ; Lee SY
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):264-73. PubMed ID: 20811057
[TBL] [Abstract][Full Text] [Related]
25. Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy.
Papageorgiou KI; Hwang CJ; Chang SH; Jarullazada I; Chokron Garneau H; Ang MJ; King AJ; Mancini R; Douglas RS; Goldberg RA
Arch Ophthalmol; 2012 Mar; 130(3):319-28. PubMed ID: 22411661
[TBL] [Abstract][Full Text] [Related]
26. [Expression of CCR1 in the orbital fibroblasts with thyroid associated ophthalmopathy].
Liu CL; Zhang XJ; Guo B; Yang JF; Luo QL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):630-2. PubMed ID: 22007486
[TBL] [Abstract][Full Text] [Related]
27. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
[TBL] [Abstract][Full Text] [Related]
28. Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.
Daumerie Ch; Duprez T; Boschi A
Eur J Intern Med; 2008 Nov; 19(7):531-6. PubMed ID: 19013383
[TBL] [Abstract][Full Text] [Related]
29. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.
Kim HC; Yoon SW; Lew H
Br J Radiol; 2015 Sep; 88(1053):20150164. PubMed ID: 26151616
[TBL] [Abstract][Full Text] [Related]
31. Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implications.
Pawlowski P; Reszec J; Eckstein A; Johnson K; Grzybowski A; Chyczewski L; Mysliwiec J
Mediators Inflamm; 2014; 2014():412158. PubMed ID: 25309050
[TBL] [Abstract][Full Text] [Related]
32. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
Yi WS; Xu XL
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-2 receptor beta and CD57 expression in orbital tissues from patients with chronic, stable thyroid-associated ophthalmopathy.
Rosen CE; Rizzuto PR; Kennerdell JS; Burde RM; Wall JR
Alaska Med; 1994; 36(4):177-82, 207. PubMed ID: 7531401
[TBL] [Abstract][Full Text] [Related]
34. Integrative metabolic analysis of orbital adipose/connective tissue in patients with thyroid-associated ophthalmopathy.
Huang J; Chen M; Liang Y; Hu Y; Xia W; Zhang Y; Zhao C; Wu L
Front Endocrinol (Lausanne); 2022; 13():1001349. PubMed ID: 36465658
[TBL] [Abstract][Full Text] [Related]
35. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue.
Lisi S; Marinò M; Pinchera A; Mazzi B; Di Cosmo C; Sellari-Franceschini S; Chiovato L
Thyroid; 2002 May; 12(5):351-60. PubMed ID: 12097194
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
[TBL] [Abstract][Full Text] [Related]
37. Integrative transcriptomics and proteomic analysis of extraocular muscles from patients with thyroid-associated ophthalmopathy.
Wu L; Zhang S; Li X; Yao J; Ling L; Huang X; Hu C; Zhang Y; Sun X; Qin B; Liu G; Zhao C
Exp Eye Res; 2020 Apr; 193():107962. PubMed ID: 32057773
[TBL] [Abstract][Full Text] [Related]
38. Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy.
Khong JJ; Wang LY; Smyth GK; McNab AA; Hardy TG; Selva D; Llamas B; Jung CH; Sharma S; Burdon KP; Ebeling PR; Craig JE
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6438-47. PubMed ID: 26444724
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
40. RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
Chen Y; Tang R; Xiong W; Zhang F; Wang N; Xie B; Cao J; Chen Z; Ma C
J Transl Med; 2023 Jun; 21(1):396. PubMed ID: 37331977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
